[INDUSTRIAL BIOTECH] Industrial Biotechnology to Enhance Biotech Sector in Malaysia

Write-up by Shushmul Maheshwari

According to our new investigation report “Emerging Biotech Sector in Malaysia”, Malaysia has witnessed an emergence of powerful interest in biotech sector considering that the adoption of National Biotechnology Policy (NBP) and had effectively recognized the industry as 1 of the key economy drivers. Driven by factors like, powerful R&ampD base, excellent government support, active private sector participation, and high investments, the Malaysian biotech market reached to the mark of US$ 180 Million in 2009 and is likely to grow at the CAGR of about 16% during 2010-2012.

Picture: Emerging Biotech Sector in Malaysia by RNCOS (Source: http://www.rncos.com/Report/IM234.htm)

 Our report has located that the industrial biotech sector is likely to contribute a main share of domestic biotechnology market place. In 2009, total revenue of BioNexus status businesses operating in industrial biotech sector reached to the mark of US$ 111 Million, which was an improve of around 35% over 2008. The segment delivers immense potential mainly due to the fact that Malaysia has a presence of huge species varieties coupled with excellent investment patterns.

The report “Emerging Biotech Sector in Malaysia” covers all the key aspects of biotechnology market and supplies present trends and reliable statistics on each of the 3 segments namely agricultural biotechnology, industrial biotechnology, and healthcare biotechnology. In every of the segments, information and analysis concerning revenue, industry players, patents scenario and so on. have been provided. The report also covers key market attractions that seek to illustrate key growth drivers of the Malaysian biotech market.

The report is an outcome of an in-depth analysis and objective analysis of the Malaysian biotech sector. It identifies and illustrates key growth drivers and trends of the business and offers brief overview of the government role. The government has been an active player of the market and as a result, the report describes key public sector methods and their impact on sector performance. Future outlook till 2012 has been provided, which makes use of dependable forecasting methods and techniques. Last but not the least, key industry players have also been covered in the report.

For No cost SAMPLE of this report go to: http://www.rncos.com/Report/IM234.htm

[REPORT CONTENT]:

Malaysia has effectively witnessed an upsurge in the profitability and development of the domestic biotechnology industry. Malaysian biotech market has been growing at the double digit rate for the past few years on the back of factors, such as rich biodiversity, active participation by the government and private players, high investments, and technological up-gradation. According to our new research report “Emerging Biotech Sector in Malaysia”, the biotech market in Malaysia reached to the mark of RM 663 Million (US$ 212 Million) in 2010 and is likely to grow at the CAGR of around 16% to reach RM 885 Million (US$ 283 Million) by 2012.

We have covered the key segments of biotechnology industry in Malaysia namely healthcare biotech, agriculture biotech, and industrial biotech. These segments are the focus areas of both the government and private market players. Under National Biotechnology Program, the authorities have extensively planned out various strategies and goals regarding each of these segments and positive developments are likely to boost revenue patterns in future.

Our report has found that agricultural biotechnology holds immense growth potential mainly due to the fact that new innovations and technological up-gradations are providing numerous advantages to this area. Marine biotechnology and crop-related biotechnology are being considered as the future growth areas. In the healthcare biotechnology segments, there are various sub-segments that are likely to witness high investments, such as contract manufacturing, CRO, drug discovery among others. The country offers a supportive environment for the global healthcare and pharmaceutical companies to build their operation. Besides, ‘BioNexus’ status provides many benefits to biotech companies.

Overall, the report analyzes all the key aspects of the Malaysian biotech industry and studies current trends and their impacts on different segments of the industry. The report also provides statistical data and an effective analysis of the macroeconomic factors, market restraints, and challenges. It also describes the role of government and regulatory mechanisms concerning industry and covers key industry players that will help clients to plan market strategies and assess areas of opportunity in the Malaysian biotech market.

Source: 

http://www.rncos.com/Report/IM234.htm

http://thebiotechdictionary.com/industrial-biotechnology-to-enhance-biotech-sector-in-malaysia